Taken together, we speculate that the c.1617del variant of TMEM260 might be a founder variant for PTA in Japan or East Asia because it is responsible for rare genetic disorders, usually resulting from recessive alleles, with a relatively high frequency in specific populations. This evidence concerns the gene TMEM260 and hereditary disease.